APG Asset Management
AMRX icon

APG Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

APG Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-99,900
Closed -$304K – 840
2022
Q2 		$304K Sell
99,900
-14,800
-13% -$53.6K ﹤0.01% 809
2022
Q1 		$430K Buy
+114,700
New +$508K ﹤0.01% 833

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

APG Asset Management's AMRX Position: Q3 2022 in Review

APG Asset Management sold out of Amneal Pharmaceuticals (AMRX) in Q3 2022, closing a stake of 99,900 shares — an estimated $304K sold.

APG Asset Management first reported a position in AMRX in Q1 2022 and held it in 2 quarters. The position peaked at $430K in Q1 2022. 154 funds tracked by Wall St. Rank hold AMRX as of Q3 2022.

  • APG Asset Management reported no remaining Amneal Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • APG Asset Management sold 99,900 Amneal Pharmaceuticals shares in Q3 2022, an estimated $304K.
  • APG Asset Management first reported a position in Amneal Pharmaceuticals in Q1 2022 and held it in 2 quarters.
  • APG Asset Management's Amneal Pharmaceuticals position peaked at $430K in Q1 2022.
  • 154 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2022.

Based on APG Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.